INTERACTIONS OF HEAVY METAL IONS WITH THE HUMAN GENOME
INTERACTIONS OF HEAVY METAL IONS WITH THE HUMAN GENOME
批准号:
7216814
负责人:
Michael Karin
金额:
$36.03万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-01-01 至 2009-03-31
关键词:
ArsenitesBiochemicalBiologicalCell LineCell ProliferationCell physiologyCellsCocarcinogenesisDiseaseDominant-Negative MutationGene ExpressionGene Expression RegulationHeavy MetalsHumanHuman GenomeI-kappa B ProteinsInflammationInflammatoryIonsLeadLinkMAPK14 geneMAPK8 geneMediator of activation proteinMitogen-Activated Protein KinasesMolecularMouse StrainsOxidantsOzonePathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologicalPlayPredispositionProtein KinaseProtein phosphataseRegulationResearch PersonnelRoleSignal Transduction PathwaySpecificityStressToxic effectTrace metalTranscription Factor AP-1Tumor PromotersTumor Promotionabstractingbaseinhibitor/antagonistsensortoxic metaltranscription factor
中文摘要
描述:(改编自研究者摘要)这是一个
继续申请一项有关微量金属影响的长期项目
离子对人类细胞基因表达的影响。 在上一阶段,我们开始
研究有毒金属离子对信号转导途径的影响
用于基因表达、细胞增殖和
生存 发现肿瘤促进剂亚砷酸盐(As+3)是一种有效的
两个丝裂原活化蛋白激酶(MAPK)级联的激活剂,
刺激转录因子AP-1的活性。 As+3的这种效应是
由于双特异性蛋白磷酸酶JNK的抑制,
磷酸酶,其正常功能是使MAPKs、JNK和p38保持在一定的水平。
低活动状态。 由于AP-1活性的诱导与
在肿瘤促进中,JNK磷酸酶可能是一个重要的介导因子,
As+3致癌作用。 它还可能参与As+3诱导的炎症反应
疾病 为了研究JNK磷酸酶的生理作用,我们将
使用生物化学的组合来表征和分子鉴定它,
和分子生物学方法。 显性阴性突变体将
转染到培养的细胞系中以抑制内源性JNK磷酸酶
活性,从而评估其在细胞生理学中的功能。 我们还将
检测JNK缺陷小鼠品系和细胞系的易感性
或JNK磷酸酶对As+3诱导的致癌作用和毒性的影响。 As+3和
其他微量金属也被认为是通过非特异性诱导作用
氧化应激。 因此,我们开始研究
转录因子NF-κ B,这被认为是一个主要的传感器,
氧化应激 我们最近纯化并克隆了一个关键成分,
导致NF-κ B活化的蛋白激酶途径,
NF-κ B抑制剂的磷酸化和最终降解,
IKB。 我们现在建议研究氧化剂
导致该IKB激酶(IKK)活化。 由于NF-κ B在
炎症,了解氧化剂对IKK活性的调节,
如臭氧,将提供氧化剂引起的炎症的分子基础
疾病
英文摘要
DESCRIPTION: (Adapted from the Investigator's Abstract) This is a
continuation application for a long-term project on effects of trace metal
ions on gene expression in human cells. During the last period, we began to
investigate the effects of toxic metal ions on signal transduction pathways
used for global regulation of gene expression, cell proliferation and
survival. The tumor promoter arsenite (As+3) was found to be a potent
activator of two mitogen activated protein kinase (MAPK) cascades that
stimulate the activity of transcription factor AP-1. This effect of As+3 is
due to inhibition of a dual-specificity protein phosphatase, JNK
phosphatase, whose normal function is to keep the MAPKs, JNK and p38 in a
low activity state. As induction of AP-1 activity is closely linked to
tumor promotion, the JNK phosphatase is probably an important mediator of
As+3 cocarcinogenesis. It may also be involved in As+3 induced inflammatory
disease. To examine the physiological role of the JNK phosphatase we will
characterize and molecularly identify it using a combination of biochemical
and molecular biological approaches. Dominant-negative mutants will be
transfected into cultured cell lines to inhibit endogenous JNK phosphatase
activity and thus assess its function in cell physiology. We will also
examine the susceptibility of mouse strains and cell lines deficient in JNK
or JNK phosphatase to As+3 induced cocarcinogenesis and toxicity. As+3 and
other trace metals were also proposed to act through non-specific induction
of oxidant stress. We therefore started to investigate the regulation of
transcription factor NF-KB, which was proposed to be a major sensor of
oxidant stress. We recently purified and cloned a key component in the
pathway leading to NF-KB activation, the protein kinase responsible for
phosphorylation and eventual degradation of the inhibitors of NF-KB, the
IKBs. We now propose to study the molecular mechanism by which oxidants
lead to activation of this IKB kinase (IKK). As NF-KB plays a key role in
inflammation, understanding the regulation of IKK activity by oxidants, such
as ozone, will provide a molecular basis for oxidant induced inflammatory
disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
-
批准号:10516935
-
项目类别:
-
资助金额:$60.06万
-
财政年份:2023
-
负责人:Michael Karin
-
依托单位:
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
-
批准号:10711615
-
项目类别:
-
资助金额:$56.39万
-
财政年份:2023
-
负责人:Michael Karin
-
依托单位:
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
-
批准号:10708168
-
项目类别:
-
资助金额:$95.5万
-
财政年份:2022
-
负责人:Michael Karin
-
依托单位:
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
-
批准号:10517874
-
项目类别:
-
资助金额:$97.11万
-
财政年份:2022
-
负责人:Michael Karin
-
依托单位:
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism
-
批准号:10503841
-
项目类别:
-
资助金额:$70.53万
-
财政年份:2022
-
负责人:Michael Karin
-
依托单位:
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism
-
批准号:10670920
-
项目类别:
-
资助金额:$68.44万
-
财政年份:2022
-
负责人:Michael Karin
-
依托单位:
The effect of cancer cell produced collagen 1 homotrimers on DDR1 signaling activation by microenvironmental collagen 1 fragments.
-
批准号:10831212
-
项目类别:
-
资助金额:$17.45万
-
财政年份:2022
-
负责人:Michael Karin
-
依托单位:
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
-
批准号:10182897
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2020
-
负责人:Michael Karin
-
依托单位:
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
-
批准号:10266224
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2020
-
负责人:Michael Karin
-
依托单位:
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
-
批准号:10322660
-
项目类别:
-
资助金额:$41.77万
-
财政年份:2019
-
负责人:Michael Karin
-
依托单位:
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
-
批准号:10083211
-
项目类别:
-
资助金额:$41.71万
-
财政年份:2019
-
负责人:Michael Karin
-
依托单位:
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
-
批准号:10735256
-
项目类别:
-
资助金额:$54.63万
-
财政年份:2019
-
负责人:Michael Karin
-
依托单位:
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
-
批准号:9886239
-
项目类别:
-
资助金额:$41.64万
-
财政年份:2019
-
负责人:Michael Karin
-
依托单位:
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors
-
批准号:10056211
-
项目类别:
-
资助金额:$55.25万
-
财政年份:2018
-
负责人:Michael Karin
-
依托单位:
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors
-
批准号:10304916
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2018
-
负责人:Michael Karin
-
依托单位:
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors
-
批准号:10533278
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2018
-
负责人:Michael Karin
-
依托单位:
The Role of IL-17 in Alcoholic Liver Disease and Cancer
-
批准号:8913875
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2014
-
负责人:Michael Karin
-
依托单位:
The Role of IL-17 in Alcoholic Liver Disease and Cancer
-
批准号:9088220
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2014
-
负责人:Michael Karin
-
依托单位:
The Role of IL-17 in Alcoholic Liver Disease and Cancer
-
批准号:8761112
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2014
-
负责人:Michael Karin
-
依托单位:
IKKalpha, autophagy, obesity and injury enhanced pancreatic cancer
-
批准号:8511588
-
项目类别:
-
资助金额:$35.99万
-
财政年份:2012
-
负责人:Michael Karin
-
依托单位:
海外基金